Anti-angiogenic activities of UFT and its metabolites, GHB and GBL, in the dorsal air sac (DAS) model in mice

Gan to kagaku ryoho. Cancer & chemotherapy

Volumn 27, Issue 1, 2000, Pages 93-98

  Basaki, Y ^a   Yonekura, K ^a   Chikahisa, L ^a   Okabe, S ^a   Hashimoto, A ^a   Miyadera, K ^a   Aoyagi, K ^a   Yamada, Y ^a  

^a TAIHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 UFT PROTOCOL; 1-UFT PROTOCOL; ANTINEOPLASTIC AGENT; GAMMA BUTYROLACTONE; OXYBATE SODIUM; TEGAFUR; URACIL;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CELL CULTURE; DRUG EFFECT; FEMALE; HUMAN; KIDNEY TUMOR; LUNG TUMOR; METABOLISM; MOUSE; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; STOMACH TUMOR; VASCULARIZATION;

4-BUTYROLACTONE; ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; HUMANS; KIDNEY NEOPLASMS; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; NEOVASCULARIZATION, PATHOLOGIC; SODIUM OXYBATE; STOMACH NEOPLASMS; TEGAFUR; TUMOR CELLS, CULTURED; URACIL;

EID: 0346163292     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)